SQNMF (Sequana Medical NV) EPS (Basic): $-1.33 (TTM As of Jun. 2025)

What is Sequana Medical NV EPS (Basic)?

Sequana Medical NV SQNMF 30 EPS (Basic) is $-1.33 as of Jun. 2025. GuruFocus rates SQNMF with a GF Score™ of 30/100 and a GF Value™ of $0.48. The stock has 12 warning signs investors should review.

Sequana Medical NV's basic earnings per share (Basic EPS) for the six months ended in Jun. 2025 was $-0.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2025 was $-1.33.

Sequana Medical NV's EPS (Diluted) for the six months ended in Jun. 2025 was $-0.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was $-1.33.

Sequana Medical NV's EPS without NRI for the six months ended in Jun. 2025 was $-0.40. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2025 was -1.33.

During the past 3 years, the average EPS without NRI Growth Rate was 2.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Sequana Medical NV's highest 3-Year average EPS without NRI Growth Rate was 2.10% per year. The lowest was -27.60% per year. And the median was -6.00% per year.

Sequana Medical NV (OTCPK:SQNMF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sequana Medical NV EPS (Basic) Related Terms

Sequana Medical NV EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Sequana Medical NV's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sequana Medical NV EPS (Basic) Chart

Sequana Medical NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-1.52

-1.47

-1.43

-1.33

-1.28

Sequana Medical NV Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25
EPS (Basic)	Get a 7-Day Free Trial														-0.70	-0.62	-0.37	-0.92	-0.40

30GF Score

Sequana Medical NV SQNMF

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sequana Medical NV EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sequana Medical NV's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-46.758	-	0)	/	36.749
	=	-1.27

Sequana Medical NV's Basic EPS for the quarter that ended in Jun. 2025 is calculated as

Basic EPS (Q: Jun. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-21.082	-	0)	/	52.420
	=	-0.40

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.33

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $-1.33 mean?

Sequana Medical NV (SQNMF) has a EPS (Basic) of $-1.33 as of Jun. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sequana Medical NV and its competitors.

Is Sequana Medical NV's EPS (Basic) too high?

Sequana Medical NV's current EPS (Basic) is $-1.33. Overall, Sequana Medical NV has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does Sequana Medical NV's EPS (Basic) compare to ABT and SYK?

Sequana Medical NV's EPS (Basic) of $-1.33 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sequana Medical NV and its competitors. Sequana Medical NV's current EPS (Basic) is $-1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sequana Medical NV stock overvalued right now?

Sequana Medical NV (SQNMF) has a current EPS (Basic) of $-1.33. The stock's GF Value™ is $0.48, compared to a current price of $1.22 — trading 154.2% above its estimated fair value. The current EPS (Basic) is $-1.33. Sequana Medical NV's overall GF Score™ is 30/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Sequana Medical NV (SQNMF), the current EPS (Basic) is $-1.33 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sequana Medical NV (SQNMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued. The current stock price of $1.22 is trading 154.2% above its estimated GF Value™ of $0.48.

Key valuation signals for SQNMF:

EPS (Basic): $-1.33
GF Value™: $0.48 vs. price of $1.22 (154.2% above fair value)
GF Score™: 30/100 with 12 warning signs

No single metric tells the full story. See the SQNMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sequana Medical NV Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XBRU:NYXH ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA STE ZBH XSWX:SOON SHSE:688271 LSE:SN.PEN TSE:7733 GMED PODD

Other Exchanges 2SE:Germany SEQUA:Belgium

Address Kortrijksesteenweg 1112, bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

30GF Score

Get the complete analysis for SQNMF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.22

Price

$0.48

GF Value

View SQNMF Analysis

See EPS (Basic) data for all stocks →